Skip to main content

Advertisement

SpringerLink
Log in

Fatigue and severity of rheumatoid arthritis in Moroccan patients

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to assess fatigue aspects in Moroccan patients with rheumatoid arthritis (RA) and its relationships with disease-specific variables especially parameters of functional and structural severity. A total of 248 patients with RA were included. Patients’ and disease characteristics were identified. Disease activity was measured clinically using physical examination, biologically and by the disease activity scores (DAS28). Radiographs were evaluated by using Sharp’s method as modified by van der Heijde. Functional disability was measured by using the Moroccan version of Health Assessment Questionnaire (HAQ). Immunological abnormalities and treatment (doses and duration) were identified. Fatigue was evaluated by using a 0–100 visual analogue scale (VAS fatigue) and the multidimensional assessment of fatigue (MAF). Quality of life (QoL) was assessed using the Arabic version of the generic instrument SF-36. The mean age of patients was 47.5 ± 11.7 years [25–72]; 37.5% of patients had a high activity of disease and 11.3% were in remission. The mean Sharp score was 107.13 ± 91, and the mean score of HAQ was 1.40 ± 0.63. All domains of QoL were deteriorated; 89.51% of our patients experienced fatigue. The mean total score of MAF was 30.21 ± 11.32. A low level of education, low socioeconomic status, atlantoaxial subluxation, hip involvement, the presence of a Sjögren syndrome, and cigarette smoking had a negative impact on fatigue scores. The severity of fatigue was correlated with the duration of RA, the intensity of joint pain, the activity of disease, the importance of structural damage, the degree of functional impairment, and the rate of anti-cyclic citrullinated protein (CCP) antibodies (P < 0.05). Patients receiving methotrexate had better scores of fatigue. Also, severity of fatigue was correlated with the deterioration of all domains of QoL. Fatigue is a major issue for our patients with RA and must be included in the routine assessment of patients. In our sample, fatigue appears to be related to disease activity, functional disability, structural damage, and immunological status and had a negative impact on QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Symmons DP (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 16(5):707–722

    Article  PubMed  Google Scholar 

  2. Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE Jr, Perfetto EM (2002) Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. Am J Manag Care 8(3):231–240

    PubMed  Google Scholar 

  3. Riemsma RP, Rasker JJ, Taal E, Griep EN, Wouters JM, Wiegman O (1998) Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. Br J Rheumatol 37(10):1042–1046

    Article  PubMed  CAS  Google Scholar 

  4. Reppin-Wuts H, Uitterhoeve R, van Riel P, van Achterberg T (2008) Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 45(7):995–1002

    Article  Google Scholar 

  5. Treharne GJ, Lyons AC, Hale ED, Goodchild CE, Booth DA, Kitas GD (2008) Predictors of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med 13(4):494–504

    Article  PubMed  CAS  Google Scholar 

  6. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatol (Oxford) 45(7):885–889

    Article  CAS  Google Scholar 

  7. Wolfe F, Hawley DJ, Wilson K (1996) The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23:1407–1417

    PubMed  CAS  Google Scholar 

  8. Hajjaj-Hassouni N, Hassouni F, Guedira N, Lazrak N (1994) La polyarthrite rhumatoïde au Maroc : à propos de 444 cas. La Semaine des hôpitaux de Paris 70:12–20

    Google Scholar 

  9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580–1588

    Article  PubMed  Google Scholar 

  10. Van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB (1995) Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp’s method (van der Heijde modification). J Rheumatol 22(9):1792–1796

    PubMed  Google Scholar 

  11. Abourazzak FE, Benbouazza K, Amine B, Bahiri R, Lazrak N, Bzami F, Jroundi I, Abouqal R, Guillemin F, Hajjaj-Hassouni N (2008) Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis. Rheumatol Int 28(12):1197–1203

    Article  PubMed  Google Scholar 

  12. Khoudri I, Ali Zeggwagh A, Abidi K, Madani N, Abouqal R (2007) Measurement properties of the short form 36 and health-related quality of life after intensive care in Morocco. Acta Anaesthesiol Scand 51(2):189–197

    Article  PubMed  CAS  Google Scholar 

  13. Geri B (2003) Neuberger. Measures of fatigue. Arthritis Rheum 49:175–183

    Article  Google Scholar 

  14. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA (2004) Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 51(4):578–585

    Article  PubMed  Google Scholar 

  15. Belza BL (1995) Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 22:639–643

    PubMed  CAS  Google Scholar 

  16. Hazes JM, Taylor P, Strand V, Purcaru O, Coteur G, Mease P. Rheumatol (Oxford). 2010 [Epub ahead of print]. Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol

  17. Huyser BA, Parker JC, Thoreson R, Smarr KL, Johnson JC, Hoffman R (1998) Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 41:2230–2237

    Article  PubMed  CAS  Google Scholar 

  18. Breedveld FC, Han C, Bala M, van der Heijde D, Baker D, Kavanaugh AF, Maini RN, Lipsky PE (2005) Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis. Ann Rheum Dis 64(1):52–55

    Article  PubMed  CAS  Google Scholar 

  19. Guobis Z, Baseviciene N, Paipaliene P, Niedzelskiene I, Januseviciūte G (2008) Aspects of xerostomia prevalence and treatment among rheumatic inpatients. Medicina (Kaunas) 44(12):960–968

    Google Scholar 

  20. Bowman SJ, Booth DA, Platts RG, UK Sjogren’s Interest Group (2004) Measurement of fatigue and discomfort in primary Sjogren’s syndrome using a new questionnaire tool. Rheumatol 43:758–764

    Article  CAS  Google Scholar 

  21. Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, Patel K, Novitzke J, Rohrer M, Gopalakrishnan R, Myers S, Nazmul-Hossain A, Emamian E, Huang A, Rhodus N, Moser K (2008) Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren’s syndrome. Arthritis Rheum 59(12):1780–1787

    Article  PubMed  Google Scholar 

  22. Vittecoq O, Lequerré T, Goëb V, Le Loët X, Abdesselam TA, Klemmer N (2008) Smoking and inflammatory diseases. Best Pract Res Clin Rheumatol 22(5):923–935

    Article  PubMed  CAS  Google Scholar 

  23. Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D, van Everdingen M, Alarcón GS, Conn DL, Jonas B, Callahan LF, Smith EA, Gilkeson G, Howard G, Moreland LW, Bridges SL Jr (2008) Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 67(11):1529–1534

    Article  PubMed  CAS  Google Scholar 

  24. Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA (2005) Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 23(6):861–866

    PubMed  CAS  Google Scholar 

  25. Kim HH, Kim J, Park SH, Kim SK, Kim OD, Choe JY (2010) Correlation of anti-cyclic citrullinated antibody with hand joint erosion score in rheumatoid arthritis patients. Korean J Intern Med 25(2):201–206

    Article  PubMed  Google Scholar 

  26. Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, Tugwell P, Crawford B, Leflunomide Rheumatoid Arthritis Investigators Groups (2005) Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol 32(4):590–601

    PubMed  CAS  Google Scholar 

  27. Söderlin MK, Lindroth Y, Jacobsson LT (2007) Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden. Rheumatol (Oxford) 46(8):1355–1358

    Article  Google Scholar 

  28. Sokka T, Hannonen P (1999) Utility of disease modifying antirheumatic drugs in “sawtooth” strategy. A prospective study of early rheumatoid arthritis patients up to 15 years. Ann Rheum Dis 58(10):618–622

    Article  PubMed  CAS  Google Scholar 

  29. Emery P, Kosinski M, Li T, Martin M, Williams GR, Becker JC, Blaisdell B, Ware JE Jr, Birbara C, Russell AS (2006) Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. J Rheumatol 33(4):681–689

    PubMed  CAS  Google Scholar 

  30. Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A (2000) Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 43(3):506–514

    Article  PubMed  CAS  Google Scholar 

  31. Fifield J, Tennen H, Reisine S, McQuillan J (1998) Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 41(10):1851–1857

    Article  PubMed  CAS  Google Scholar 

  32. Strand V, Singh JA (2010) Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs 70(2):121–145

    Article  PubMed  CAS  Google Scholar 

  33. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A (1997) Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 36(5):551–559

    Article  PubMed  CAS  Google Scholar 

  34. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes. 7:25

    Article  PubMed  Google Scholar 

  35. West E, Wållberg-Jonsson S (2009) Health-related quality of life in Swedish men and women with early rheumatoid arthritis. Gend Med 6(4):544–554

    Article  PubMed  Google Scholar 

  36. Lillegraven S, Kvien TK (2007) Measuring disability and quality of life in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 21(5):827–840

    Article  PubMed  Google Scholar 

  37. Alishiri GH, Bayat N, Fathi Ashtiani A, Tavallaii SA, Assari S, Moharamzad Y (2008) Logistic regression models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients. Mod Rheumatol 18(6):601–608

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology, El Ayachi Hospital, University Hospital of Rabat-Sale, 11000, Sale, Morocco

    Yousra Ibn Yacoub, Bouchra Amine, Assia Laatiris, Fahd Wafki, Fatima Znat & Najia Hajjaj-Hassouni

Authors
  1. Yousra Ibn Yacoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bouchra Amine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Assia Laatiris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fahd Wafki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fatima Znat
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Najia Hajjaj-Hassouni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yousra Ibn Yacoub.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibn Yacoub, Y., Amine, B., Laatiris, A. et al. Fatigue and severity of rheumatoid arthritis in Moroccan patients. Rheumatol Int 32, 1901–1907 (2012). https://doi.org/10.1007/s00296-011-1876-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-1876-0

Keywords

Search

Navigation